It has been said that "α-emitters are indispensable with regard to optimisation of strategies for tumour therapy".[4]
^Committee on State of the Science of Nuclear Medicine; National Research Council; Division on Earth and Life Studies; Institute of Medicine; Nuclear and Radiation Studies Board; Board on Health Sciences Policy (2007). "Targeted Radionuclide Therapy". Advancing nuclear medicine through innovation. Washington, D.C.: National Academies Press. doi:10.17226/11985. ISBN978-0-309-11067-9. PMID20669430. {{cite book}}: |last6= has generic name (help)